The etiology of acute lung injury is complex and associated with numerous, chemically diverse precipitating factors. During acute lung injury in mice, one key event is epithelial cell injury that leads to reduced surfactant biosynthesis. We have previously reported that transgenic mice that express transforming growth factor alpha (TGFA) in the lung were protected during nickel-induced lung injury. Here, we find that the mechanism by which TGFA imparts protection includes maintenance of surfactant associated protein B (SFTPB) transcript levels and epidermal growth factor receptor-dependent signaling in distal pulmonary epithelial Together, these findings support that maintenance of SFTPB expression is critical to survival during acute lung injury.
INTRODUCTION
Acute lung injury is clinically manifested by a low arterial oxygen, protein-rich edema, capillary injury, and diffuse alveolar epithelial cell damage (1). The incidence of acute lung injury in the US has been estimated at 194,000 cases/yr, and although many clinical trials have been attempted, survival remains low and unpredictable (74,000 deaths/yr) (2) . The etiology of acute lung injury is complex and can be induced by numerous causes including sepsis, trauma, pneumonia, and inhaled irritants (3, 4) . Several laboratory animal models have been developed to investigate the clinical features of lung injury in vivo. To begin to identify the genetic determinants and understand the molecular basis of gene-environmental interactions that control survival during irritant-induced lung injury, mice were exposed to nickel, which produced lethal lung injury, marked by alveolar epithelial damage, edema, perivascular distention, hemorrhage, and neutrophil infiltration (5, 6) .
To map the genetic loci controlling survival, we previously performed a quantitative trait locus (QTL) analysis and found that survival during lung injury is a complex trait and dependent on interactions among multiple chromosomal regions (6, 7) . Candidate genes that map to a significant QTL interval on chromosome 6 included transforming growth factor alpha (Tgfa), which previously had been noted to increase in the bronchoalveolar lavage (BAL) fluid of patients with acute lung injury (8) . While the precise physiologic role of TGFA in lung injury is not completely understood, over-expression of human TGFA in the distal lung under the control of a human surfactant associated protein C (SFTPC) promoter protected transgenic mice against nickel-induced lung injury, markedly increasing survival (9) . However, the molecular determinants of TGFA-mediated protection have not been clearly defined. The purpose of this study was to determine whether TGFA contributes to survival during nickel-induced injury by maintaining the expression of critical genes, including surfactant-associated proteins. To examine the mechanism of TGFA protection, we assessed transcripts altered during nickelinduced lung injury, how nickel alters SFTPB expression in vitro, and whether maintenance of SFTPB could increase survival.
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METHODS
Experimental design: All studies performed were approved by the Institutional Animal Care and Use Committee of the University of Cincinnati. Previously we determined that transgenic mice with a constitutive human TGFA transgene directed to the respiratory epithelium under the control of human SFTPC promoter were protected from nickel-induced lung injury (9) . Our in vivo and in vitro studies here were aimed at understanding the molecular basis of nickel-induced injury survival. First, we measured survival in TGFA transgenic mice exposed to nickel. To determine whether epidermal growth factor receptor (EGFR) expressed on alveolar epithelial cells plays a role in survival, we exposed transgenic mice constitutively expressing human TGFA and bitransgenic mice constitutively expressing TGFA and dominant negative EGFR to nickel. Both transgenes were under the control of human SFTPC promoter. Second, because these mice display varied survival, we contrasted the lung mRNA profiles of these mice during nickel-induced injury using quantitative real-time polymerase chain reaction (qRT-PCR) assays.
Third, mouse lung epithelial (MLE-15) cells (10) were used to investigate alteration in the transcriptional profile and Sftpb regulation. Fourth, to determine if maintenance of SFTPB expression can improve survival, we exposed transgenic mice that have SFTPB expression directed to lung epithelial cells under the control of a dox sensitive promoter to nickel.
Transgenic mice:
The generation and characterization of the transgenic mice used in this study have been described previously (11) (12) (13) (14) (15) . All mice were derived from the FVB/NJ strain and housed in a pathogen-free environment. Transgenic mice expressing human TGFA in the pulmonary epithelium can be protected against nickel-induced lung injury (11) .
The mouse lines we used included: (A) constitutive TGFA transgenic mice (Line 28) in which the human TGFA transgene is under the control of the human SFTPC promoter, (B) TGFA Line 28 x dn mutEGFR mice generated by crossing TGFA transgenic mice with mice that expressed dominant negative mutant EGFR under the control of the human SFTPC promoter (13, 14) , and (15) . The Scgb1a1-rtTA /TetO 7 SFTPB/Sftpb -/-mice are offspring of Sftpb +/-dams given dox in the drinking water from day 0 of gestation to stimulate transcription of the SFTPB transgene during fetal lung development, and can survive when maintained on dox. These mice were compared to Scgb1a1-rtTA /TetO 7 SFTPB/Sftp +/+ littermates treated with doxycycline.
Mouse exposure and nickel aerosol generation: Mice (6-9 weeks old) were placed in a 0.32 m 3 stainless steel inhalation chamber as described previously (6) . Nickel aerosol (150 µg Ni/m 3 , 0.5 µm mass median aerodynamic diameter) was generated from 50 mM NiSO 4 . 6H 2 O (Sigma Chemical Co, St Louis, MO). The nickel concentration in the chamber was determined using the methylglyoxime method (16 Data were analyzed using least median squares regression analysis to distinguish differences between untreated control and NiSO 4 -treated samples.
Promoter analysis for transcription factor binding site enrichment: To identify putative acute lung injury-related transcriptional factors critical to nickel-induced injury susceptibility, we acquired promoter sequences (-2000 bp upstream from the tentative transcription start site) of genes whose mRNA levels were increased or decreased following NiSO 4 treatment and searched for over-represented transcription factor binding sites in these sequences using MatInspector (Genomatix, Munich, Germany) as described previously (19). Following treatment of MLE-15 cells with nickel, SFTPB mRNA levels were measured by S1 nuclease protection assays as described previously (7, 20) . Ribonuclease protection assays were performed to assess mRNA levels of AP-1 family members. Riboprobes specific for mouse Jun, Fos, Jund, and Junb, and Rpl32 were radiolabeled with [α- Figure 2C) , and surfactant associated protein biosynthesis ( Figure 2D ). We reasoned that the transcripts most critical in nickel-induced injury would exhibit contrasting expression patterns in protected vs. sensitive mice.
The transcript levels analyzed for the innate immunity and antioxidant categories increased similarly in all groups of mice (Figure 2A and 2B) . In contrast, transcripts for surfactant lipid and surfactant associated proteins ( Figure 2C and 2D ) decreased in the sensitive mice but not in protected mice. This difference in transcript levels suggests that maintenance of surfactant synthesis plays a critical role in determining the outcome.
In addition, the reversal of diminished surfactant synthesis appears to be critical to survival during nickel-induced injury. One possible outcome that could lead to protection would be improved capacity to handle oxidative stress. However, antioxidant transcripts (e.g., Gclc) were similar among groups. In addition, another possible outcome that would lead to protection would be a decrease in inflammation. However, innate immunity transcripts (e.g., Cxcl2) remain similar among groups. Because decreases in transcript levels do not always reflect functional differences, these changes should be viewed with caution. The lack of change in transcript levels alone does not rule out that differences in inflammation occurred.
Nickel decreased SFTPB mRNA in MLE-15 cells: Of the multiple surfactant associated proteins (SFTPA, B, C, and D), maintenance of SFTPB expression has been found to be the most important in determining survival (15, 25) . To further understand the mechanism by which nickel inhibits SFTPB expression, SFTPB mRNA levels in mouse lung epithelial (MLE-15) cells
were assessed by S1 nuclease protection assay. SFTPB transcript levels were decreased in a dose-and time-dependent manner. Levels of SFTPB mRNA were unchanged at 100 µM but decreased in MLE-15 cells following treatment with 300, 600, and 1000 µM NiSO 4 for 24 h (38+3%, 11+1%, and 10+1% of control, respectively, mean + SE, p<0.05) ( Figure 3A ).
Significant inhibition of SFTPB mRNA was delayed, being observable 18 and 24 h after initiation of treatment with 300 µM NiSO 4 (65+8% and 38+3 % of control, respectively, mean + SE, p<0.05) ( Figure 3B ). To assess whether these doses were cytotoxic, we tested MLE-15 cells with nickel concentrations of 100, 300, and 600 µM and found that these doses produced minimal cytotoxicity (0.1+2.0%, 0.3+3.0%, and 5.8+4.3% LDH release/24 h, respectively, mean + SE, each value is not significantly different than vehicle-treated control, ANOVA). Transcripts with the greatest increases (Table S1 ) and decreases (Table S2 ) are presented as supplementary data.
Analysis of transcriptional changes in nickel-
To ascertain molecular pathways altered in MLE-15 cells following treatment, computational analysis was used to identify overrepresented GO categories among genes with significantly altered expression. Among 522 significantly increased transcripts (FDR ≤ 0.05), GO categories determined to be overrepresented (FDR ≤ 0.01) are summarized in Table 1 . Particularly, several GO categories related to glucose processing (e.g., glycolysis, glucose metabolism and catabolism), which is critical to improved cell survival during stress (26), were significantly overrepresented. Additionally, among 497 significantly decreased genes (FDR ≤ 0.05), GO categories determined to be significantly overrepresented (FDR ≤ 0.01) are summarized in Table 2 . Notably, the prevalence of GO categories related to nucleotide biosynthesis and metabolism were significantly enriched in transcripts that decreased.
To discern putative regulatory mechanisms that may underlie the lung epithelium's differential transcriptional response to nickel treatment, we performed computational promoter analysis (25) with this microarray dataset. Transcription factors were selected to determine the recognition elements that were enriched in the promoters of genes with significantly increased and decreased expression ( Table 3) . Among increased transcripts, E2F transcription factor 1 (E2F-1), AP-2, sterol regulatory element-binding protein (SREBP), trans-acting transcription factor 1 (SP1), peroxisome proliferators-activated receptor (PPAR), nuclear factor kappa B (NF-κB), and hepatocyte nuclear factor-4 (HNF-4) were determined to be significantly enriched in the promoters (p < 0.05) ( Table 3) . Among decreased transcripts, only AP-1 was determined to be significantly enriched (p < 0.01). The recognition site for cyclic AMP response elements (CRE-ATF and CREB), Nuclear factor of activated T-cells (NFAT), E twenty six-domain (ETS)
were tested but were not enriched significantly in either group of transcripts.
Together with the DNA binding analysis, the computational analysis suggests that the transcription factors most consistently altered by nickel included AP-1, AP-2, and E2F-1. The microarray analysis was not used to test for MTF1 because this motif is relatively uncommon. inhibition of Sftpb expression, promoter constructs encompassing nucleotides -100/+35 and nucleotides -397/-272, respectively, were used to drive luciferase reporter activity. Coexpression of Jun inhibited the pGL4 -397/-272, but not pGL4 -100/+35, Sftpb promoter reporter activity ( Figure 6B ). These findings demonstrate that the distal, but not the proximal, Sftpb promoter region mediates Jun dependent inhibition of SFTPB expression. food from day 0 of gestation. We reasoned that maintaining these mice on dox during nickel exposure would increase survival because unlike the nascent promoter, the inducible transgene could be insensitive to the nickel-induced Jun inhibition. Maintenance of SFTPB under the control of a dox sensitive promoter system increased survival in mice during nickel-induced injury as compared to control mice (Figure 7) , albeit not as long as TGFA transgenic mice (Figure 1 ). These results demonstrate that SFTPB expression contributes to the protection against nickel-induced injury.
The protective role of SFTPB expression against nickel-induced injury:
DISCUSSION
Previously, we reported that transgenic mouse lines with varying human TGFA expressed in the lung were protected during nickel-induced lung injury in a concentration dependent manner (11) . Transgenic TGFA mice with the dominant negative mutant EGFR (TGFA Line 28 x dnmutEGFR) survived less than TGFA transgenic mice (Figure 1) . These mice lacked a portion of the EGFR intracytoplasmic domain, but contained the EGFR transmembrane and extracellular ligand-binding domains (13) . The reversal was partial possibly because the dn-mutEGFR produced partial inhibition of EGFR signaling (complete inhibition would be embryonic lethal).
Because the dn-mutEGFR was constructed under control of the human SFTPC promoter, the transgene is expressed principally in type II alveolar and distal bronchiolar epithelial cells. This Gene-targeted mice lacking SFTPB (25), but not SFTPC (47), succumb to respiratory failure shortly after birth. SFTPB deficiency also causes respiratory failure in adult mice (15) .
Therapeutic application of surfactant preparations to premature infants with acute respiratory distress syndrome reduces mortality and has become routine clinical practice (48, 49).
However, whether surfactant therapy can be improved to reduce mortality in adult acute lung injury remains a major therapeutic challenge (50, 51). One possible corollary to our findings of the critical role for SFTPB is the support for future therapy directed at maintaining differentiated function of type II alveolar cells and SFTPB biosynthesis during acute lung injury (1).
If inhibition of Sftpb expression contributes to nickel-induced injury, then maintenance of SFTPB should protect mice and improve survival. In support of this hypothesis, the survival of conditional transgenic mice in which dox was used to control SFTPB expression instead of the native promoter was greater than control FVB/NJ mice following nickel exposure (Figure 7) .
However, it is also clear that, unlike TGFA expression, SFTPB alone may not be sufficient to obtain the level of protection imparted by TGFA during nickel-induced injury. As noted above, several other lung transcripts involved in surfactant synthesis were decreased during exposure and could also contribute to the increased survival in resistant mice. Of the transcripts that are restored in the resistant mouse line, NAPSA and SFTPC are particularly noteworthy. NAPSA is necessary for protein processing of SFTPB (31), and SFTPC is critical to rapid and efficient adsorption of surfactant phospholipids into the air-liquid interface (52).
In summary, SFTPB production capacity is reduced during nickel-induced injury in mice and survival is enhanced when SFTPB is maintained. TGFA-EGFR signaling in the pulmonary epithelium contributes to survival. However, the molecular mechanism for this protection is C, 24 h) with 600µM NiSO 4 and mRNA analyzed by oligonucleotide microarray. Using the complete Genomatix Vertebrate Matrix Library 6.2, the p value was calculated using binomial distribution probability by comparing the matrix match of the promoter regions of differentially expressed genes with the promoters from random mouse genes sets (-2kb for all the promoters). The single-step Bonferroni adjustment is used to control for the multiple comparisons effect (i.e., multiplication of p-value by the number of transcription factor binding sites in Genomatix Vertebrate Matrix Library). For the analysis, transcription factors were considered significantly enriched in the gene promoters (p ≤ 0.05). , and FDR ≤ 0.01. Molecular functions were derived from the Mouse Genome Informatics (MGI) Gene Ontology (GO) Consortium. Lung = previously reported to be found in lung or lung cells.
